Connection

Aldo Maggioni to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Aldo Maggioni has written about Randomized Controlled Trials as Topic.
Aldo Maggioni
Connection Strength
0.313
Randomized Controlled Trials as Topic
  1. [COVID-19 trials: surfing between expectations and illusions, looking forward to evidence]. G Ital Cardiol (Rome). 2020 Jul; 21(7):479-482.
    View in: PubMed
    Score: 0.054
  2. EuroHeart: European Unified Registries On Heart Care Evaluation and Randomized Trials. Eur Heart J. 2019 09 01; 40(33):2745-2749.
    View in: PubMed
    Score: 0.051
  3. [The REVEAL study]. G Ital Cardiol (Rome). 2018 Feb; 19(2):71-76.
    View in: PubMed
    Score: 0.046
  4. Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial. JACC Heart Fail. 2017 07; 5(7):471-482.
    View in: PubMed
    Score: 0.044
  5. Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial. Can J Cardiol. 2017 08; 33(8):1027-1035.
    View in: PubMed
    Score: 0.044
  6. Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care. J Clin Endocrinol Metab. 2019 08 01; 104(8):3296-3302.
    View in: PubMed
    Score: 0.013
  7. Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial. JACC Heart Fail. 2019 10; 7(10):862-874.
    View in: PubMed
    Score: 0.013
  8. [ANMCO/ANCE/ARCA/GICR-IACPR intersociety consensus document: long-term antiplatelet therapy in patients with coronary artery disease]. G Ital Cardiol (Rome). 2018 May; 19(5):263-331.
    View in: PubMed
    Score: 0.012
  9. Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Circulation. 2017 10 17; 136(16):1560-1562.
    View in: PubMed
    Score: 0.011
  10. Declining Risk of Sudden Death in Heart Failure. N Engl J Med. 2017 07 06; 377(1):41-51.
    View in: PubMed
    Score: 0.011
  11. Mechanisms linking empagliflozin to cardiovascular and renal protection. Int J Cardiol. 2017 Aug 15; 241:450-456.
    View in: PubMed
    Score: 0.011
  12. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005]. G Ital Cardiol (Rome). 2007 Feb; 8(2):102-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.